# Probiotics for the Treatment of Irritable Bowel Syndrome in Celiac Patients

> **NCT01699191** · NA · UNKNOWN · sponsor: **University of Bari** · enrollment: 120 (estimated)

## Conditions studied

- IBS in Celiac Desease

## Interventions

- **DIETARY_SUPPLEMENT:** Probiotic
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT01699191
- **Lead sponsor:** University of Bari
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-10
- **Primary completion:** 2013-10
- **Final completion:** 2014-01
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2012-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01699191

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01699191, "Probiotics for the Treatment of Irritable Bowel Syndrome in Celiac Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01699191. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
